Subscribe To
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022
HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...
March 2, 2022, 8:05 am
Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022
HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...
March 2, 2022, 8:05 am
Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022
HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for ...
March 2, 2022, 8:05 am
New study questions pfizer vaccine effectiveness in kids
CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...
March 1, 2022, 8:49 pm
New study questions pfizer vaccine effectiveness in kids
CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...
March 1, 2022, 8:49 pm
New study questions pfizer vaccine effectiveness in kids
CNBC's Meg Tirrell joins Shep Smith to report on a new study that raises questions about the effectiveness of Pfizer's v...
March 1, 2022, 8:49 pm
Why novavax stock is jumping today
Investors like the vaccine maker's 2022 revenue outlook....
March 1, 2022, 12:13 pm
Why novavax stock is jumping today
Investors like the vaccine maker's 2022 revenue outlook....
March 1, 2022, 12:13 pm
Why novavax stock is jumping today
Investors like the vaccine maker's 2022 revenue outlook....
March 1, 2022, 12:13 pm
Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds
Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...
March 1, 2022, 11:43 am
Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds
Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...
March 1, 2022, 11:43 am
Pfizer covid-19 vaccine 12% effective against omicron in kids 5-11, study finds
Yahoo Finance's Anjalee Khemlani joins the Live show to report new findings on Pfizer's COVID-19 vaccin...
March 1, 2022, 11:43 am
Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...
March 1, 2022, 11:34 am
Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...
March 1, 2022, 11:34 am
Cardiol therapeutics receives clearance to expand eligible patient group for its lancer study
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food and Drug Administration and its counterparts in ...
March 1, 2022, 11:34 am
Novavax's revenue falls short. management expects a surge.
The Covid-19 vaccine maker Novavax expects revenue of between $4 billion and $5 billion in 2022, That c...
March 1, 2022, 6:29 am
Novavax's revenue falls short. management expects a surge.
The Covid-19 vaccine maker Novavax expects revenue of between $4 billion and $5 billion in 2022, That c...
March 1, 2022, 6:29 am